Key facts
- Notable investors include Eight Roads, OriGYN (Medical Supplies), Weixi (Suzhou) Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for IngeDx Diagnosis
- ·The full record, as it builds
Funding rounds
No funding rounds for IngeDx Diagnosis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IngeDx Diagnosis
Developer of thin-film microfluidics platform designed for diagnosis. The company's thin-film microfluidics platform realizes precise control and detection of microfluid flow rate, flow direction, transfer, quantification, and temperature change, which can help patients get rapid in vitro diagnostic testing solutions, providing customers with accurate and high-quality diagnosis results.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2020
- Website
- ingedx.com/
- Ownership
- Privately Held (backing)
IngeDx Diagnosis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IngeDx Diagnosis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IngeDx Diagnosis in its N-PORT filings yet. We sweep new filings monthly.